Tyra Biosciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $1.00K.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $1.00K.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $1.00K.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $86.00K.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $632.00K, a 610.11% increase from fiscal 2021.
- Tyra Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $89.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $632.00K 10-K · filed 2024-03-19 | |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-03 | $89.00K 10-K · filed 2022-03-03 |
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.00K 10-Q · filed 2021-11-03 | |
| 2021-03-31 | $86.00K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |